[Chances of Artificial Intelligence and Big Data for the Diagnosis and Treatment of Age-related Macular Degeneration].
Journal:
Klinische Monatsblatter fur Augenheilkunde
PMID:
31671463
Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in the western world. Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is an effective therapy of the neovascular form of this condition. Multimodal imaging and standardised electronic patient documentation have helped to improve the diagnosis and management of AMD patients recent years. With the advent of artificial intelligence and big data, there are many opportunities for the future. This article is intended to give an overview of possible applications.